Samsung Medical Center
Why do patients choose the Republic of Korea for lymphoma chemotherapy?
Access advanced Lymphoma chemotherapy solutions in trusted clinics .
| Republic of Korea | Turkey | Austria | |
| Lymphoma chemotherapy | from $22,500 | from $3,000 | from $8,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Lymphoma chemotherapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Lymphoma chemotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Lymphoma chemotherapy journey.
Day 1
Day 2
Day 3-4
Day 5
Week 2-6
Week 7 onwards
Please note that the above timeline is a general guideline and individual cases may vary.
Prof. Keun Chil Park, MD is a hematologist-oncologist who graduated from Seoul National University College of Medicine. He specializes in lung, head and neck, and esophageal cancer and is a member of multiple professional organizations, including the Korean Medical Association, the Korean Association of Internal Medicine, the Korean Cancer Association, the American Society of Clinical Oncology, the American Association for Cancer Research, the European Society of Medical Oncology, the International Association for the Study of Lung Cancer, and the Korean Association for Clinical Oncology.
South Korea reports high survival rates for lymphoma, with a general 72.9% 5-year relative survival across all cancers. Specific subtypes like MALT lymphoma reach 98.6% survival. Outcomes for Diffuse Large B-cell Lymphoma (DLBCL) improved to over 61% following the adoption of R-CHOP chemotherapy protocols.
Bookimed Expert Insight: High patient volumes at Seoul centers correlate with superior survival outcomes. Severance Hospital and Samsung Medical Center treat over 6 million patients combined annually. This massive scale allows oncologists to refine R-CHOP and ABVD protocols, maintaining success rates that rival or exceed global benchmarks.
Patient Consensus: Patients emphasize that early diagnosis at major Seoul hospitals leads to 80-90% survival. Many note that Korea's efficient, tech-driven medical system ensures no missed chemotherapy cycles.
South Korea’s primary centers for lymphoma chemotherapy include the Big 5 university hospitals in Seoul, led by Samsung Medical Center and Asan Medical Center. These JCI-accredited facilities integrate advanced hematologic Malignancy Centers, offering specialized R-CHOP protocols and stem cell transplantation for aggressive subtypes.
Bookimed Expert Insight: While all Big 5 hospitals offer elite care, Severance Hospital stands out for international logistics. Their patient navigator system manages the complex scheduling required for multi-cycle chemotherapy. This significantly reduces the administrative burden for patients traveling from abroad compared to larger, higher-volume public centers.
Patient Consensus: Patients emphasize the efficiency of the international clinics, noting that having translated medical records ready significantly accelerates treatment planning. Many also highlight the seamless transition from intensive chemotherapy to stem cell transplants at Asan Medical Center.
South Korea provides advanced CAR-T cell therapy and heavy ion therapy for lymphoma. Major Seoul-based hospitals like Samsung Medical Center and Severance Hospital utilize these precision treatments for relapsed diffuse large B-cell lymphoma. These facilities hold Joint Commission International and KOIHA accreditations.
Bookimed Expert Insight: Samsung Medical Center and Severance Hospital represent the highest concentration of specialized cancer technology in Korea. While Severance leads in heavy ion therapy, Samsung serves over 2 million patients annually. Their high volume translates to significant experience with complex hematologic cases. Patients should prioritize these Seoul-based giants for the newest treatment protocols.
Patient Consensus: Patients report that while revolutionary therapies are domestically available, waitlists at major Seoul hospitals are often long. Many advise getting multiple assessments at different clinics to clarify immediate therapy options.
International patients must provide a medical visa (C-3-3 or G-1-10), an official hospital invitation, and a doctor's letter confirming the treatment plan. Essential clinical documentation includes English-translated pathology reports, biopsy slides for local re-verification, and recent PET or CT scans from specialized oncology centers.
Bookimed Expert Insight: Data from top-tier institutions like Severance Hospital and Samsung Medical Center shows they prioritize patients who submit pathology results 2 months early. Since these JCI-accredited centers often require local re-verification of slides, early digital submission secures treatment slots faster and prevents diagnostic delays upon arrival in Seoul.
Patient Consensus: Patients emphasize bringing physical biopsy slides rather than just digital reports, as Korean specialists frequently conduct their own lab analysis. Having cash reserves for upfront payments is also recommended to streamline the initial admission process.